Published in Women's Health Weekly, May 26th, 2005
Study 1: Complimentary use of array-CGH (comparative genomic hybridization) and tissue microarrays can help identify prognostic markers in breast cancer cases, suggest oncologists.
"Gene amplification, an important mechanism of oncogene activation in breast cancer, can have both prognostic and therapeutic implications. In this work, an attempt is made to identify amplified genes that can be used to improve prognostication in breast cancer," said G. Callagy and colleagues, University of Cambridge, U.K.
They screened "a series of 52...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.